Cabardo, Skyler Finn P.
HRN: 28-53-95 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
AMPICILLIN 1GM (VIAL)
02/24/2026
03/03/2026
IV
165mg
Q12H
T/C Neonatal Pneumonia
Checking Initial Appropriateness
02/24/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/24/2026
03/03/2026
IV
50mg
Q24H
T/C Neonatal Pneumonia
Checking Initial Appropriateness
02/27/2026
CEFTAZIDIME 1GM (VIAL)
02/27/2026
03/06/2026
IV
110mg
Q8h
T/C Neonatal Pneumonia
Checking Initial Appropriateness